Sharps Compliance CORP: management transactions · United States · SEC (Form 4)

About Sharps Compliance CORP

Sharps Compliance Corp. (ticker: SMED) is a U.S.-based specialist in regulated waste management, historically focused on medical, pharmaceutical, and other sensitive waste streams generated by small and mid-sized producers. The company was formed in November 1992 as a Delaware corporation and is headquartered in Houston, Texas, United States. SMED was listed on NASDAQ, placing it in the U.S. small-cap universe where regulatory exposure, service specialization, and recurring compliance-driven demand are key investment themes. From a business-model perspective, Sharps Compliance built its franchise around full-service solutions for the collection, transportation, treatment, and disposal/recycling of regulated waste. Its customer base included healthcare facilities, laboratories, pharmacies, physician offices, and other organizations that generate medical or pharmaceutical waste on a moderate scale. The company also served end-markets linked to unused prescription drugs and other compliance-sensitive materials. A notable part of its offering included mail-back and integrated waste-management solutions, designed to simplify logistics for customers while addressing strict regulatory requirements. That positioning gave Sharps a differentiated niche: it was not just a hauler, but a compliance partner for organizations that need a reliable, outsourced pathway for hazardous and healthcare-related waste. Historically, the company expanded both organically and through targeted acquisitions. One concrete example is the February 2022 acquisition of Midwest Medical Waste, a route-based medical waste management provider with more than 600 locations in Kansas. SEC filings also indicate that Sharps operated treatment facilities in Carthage, Texas, and Nesquehoning, Pennsylvania, alongside corporate offices in Houston. This footprint underscores a multi-site operating model within the United States, built to support national service coverage and local logistics execution. In competitive terms, Sharps operated in a fragmented but highly regulated market. The main barriers to entry are not simply capital intensity; they also include permitting, handling expertise, transport compliance, and customer trust. That creates a defensible niche for operators that can reliably manage regulated waste streams and help customers reduce compliance risk. For investors, such a model can be attractive because demand is tied to ongoing regulatory obligations rather than discretionary spending, although the business can still be sensitive to execution risk, acquisitions, and cost structure. A major recent corporate development was the July 2022 announcement that Sharps Compliance had entered into a definitive merger agreement to be acquired by an affiliate of Aurora Capital Partners. That transaction materially changed the company’s public-market profile and should be taken into account when evaluating its historical stock-market behavior and insider-trading filings. In short, SMED is best understood as a U.S. environmental services and compliance platform with a long operating history, a specialized healthcare-waste focus, national reach, and a NASDAQ listing in the United States.